{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:04:00Z","timestamp":1794693840672,"version":"4.9.1"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jneuroim.2026.578942","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:16:56Z","timestamp":1776957416000},"page":"578942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["TGR5 and FXR receptors in motor degeneration: Molecular mechanism, crosstalk pathways and therapeutic prospects"],"prefix":"10.1016","volume":"417","author":[{"given":"Souvik","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drishti","family":"Panjwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shareen","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2026.578942_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2016.00263","article-title":"Bile acids in neurodegenerative disorders","volume":"8","author":"Ackerman","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.630569","article-title":"Nuclear receptors as multiple regulators of NLRP3 inflammasome function","volume":"12","author":"Alatshan","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0015","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.jmb.2019.03.006","article-title":"Microglia-specific metabolic changes in neurodegeneration","volume":"431","author":"Aldana","year":"2019","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578942_bb0020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12035-023-03561-y","article-title":"Role of brain Liver X receptor in Parkinson\u2019s disease: hidden treasure and emerging opportunities","volume":"61","author":"Alnaaim","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0025","article-title":"Amyotrophic Lateral Sclerosis pathoetiology and pathophysiology: roles of astrocytes, gut microbiome, and muscle interactions via the mitochondrial Melatonergic Pathway, with disruption by Glyphosate-based herbicides","volume":"24","author":"Anderson","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0030","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.3390\/ijms26104904","article-title":"Genetic basis of motor neuron diseases: insights, clinical management, and future directions","volume":"26","author":"Antonakoudis","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000335675","article-title":"Mitochondria and oxidative stress in the cardiorenal metabolic syndrome","volume":"2","author":"Aroor","year":"2012","journal-title":"Cardiorenal Med."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0040","first-page":"120","article-title":"AMPK signaling pathway as a potential therapeutic target for parkinsons disease","volume":"14","author":"Athari","year":"2023","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0045","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/microorganisms3040641","article-title":"The gut microbiota as a therapeutic target in IBD and metabolic disease: a role for the bile acid receptors FXR and TGR5","volume":"3","author":"Baars","year":"2015","journal-title":"Microorganisms"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0050","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.24537","article-title":"Dual farnesoid x receptor\/TGR5 agonist INT-767 reduces liver injury in the mdr2\u2212\/\u2212 (abcb4\u2212\/\u2212) mouse cholangiopathy model by promoting biliary HCO3\u2212 output","volume":"54","author":"Baghdasaryan","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/biof.70078","article-title":"Bile acids as key mediators of the Gut Microbiota\u2013Immune Axis: potential biomarker and therapeutic perspectives","volume":"52","author":"Baldi","year":"2026","journal-title":"Biofactors"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.786475","article-title":"Exploiting focused ultrasound to aid intranasal drug delivery for brain therapy","volume":"13","author":"Barbato","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578942_bb0065","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00281-022-00935-7","article-title":"Bile acids and their receptors: modulators and therapeutic targets in liver inflammation","volume":"44","author":"Bertolini","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/0115665232292246240426125504","article-title":"Advancements in CRISPR-based therapies for genetic modulation in neurodegenerative disorders","volume":"25","author":"Bhushan","year":"2024","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0075","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1113\/jphysiol.2014.271155","article-title":"Neuro-humoral signalling by bile acids and the TGR5 receptor in the gastrointestinal tract","volume":"592","author":"Bunnett","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262311301","article-title":"Emerging roles of bile acids in neuroinflammation","volume":"26","author":"Butcher","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9100964","article-title":"The impact of mitochondrial deficiencies in neuromuscular diseases","volume":"9","author":"Cant\u00f3-Santos","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0090","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3390\/ijms18102092","article-title":"Neuromuscular junction dismantling in amyotrophic lateral sclerosis","volume":"18","author":"Cappello","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0095","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/17460441.2023.2216014","article-title":"What are the current trends in g protein-coupled receptor targeted drug discovery?","volume":"18","author":"Casad\u00f3","year":"2023","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26125782","article-title":"Oxidative stress in neurodegenerative disorders: a key driver in impairing skeletal muscle health","volume":"26","author":"Castelli","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0105","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2576657","article-title":"Unraveling multiple sclerosis: a hidden interaction between intestinal microbiota and host lipid metabolism","volume":"17","author":"Cen","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0110","article-title":"Gut microbiota: a novel target for exercise-mediated regulation of NLRP3 inflammasome activation","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0115","doi-asserted-by":"crossref","DOI":"10.1186\/s43556-025-00307-1","article-title":"Microbiota\u2013gut\u2013brain axis in neurodegenerative diseases: molecular mechanisms and therapeutic targets","volume":"6","author":"Chen","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0120","doi-asserted-by":"crossref","first-page":"8366","DOI":"10.1039\/D1FO01360B","article-title":"Protective effects of berberine against MPTP-induced dopaminergic neuron injury through promoting autophagy in mice","volume":"12","author":"Deng","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0125","article-title":"Microbiota\u2013gut\u2013brain axis and bile acids\u2013driven neuromodulation","author":"Dong","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0130","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162246","article-title":"Glucocorticoid receptor-dependent therapeutic efficacy of tauroursodeoxycholic acid in preclinical models of spinocerebellar ataxia type 3","volume":"134","author":"Duarte-Silva","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0135","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.dld.2013.10.021","article-title":"The bile acid TGR5 membrane receptor: from basic research to clinical application","volume":"46","author":"Duboc","year":"2014","journal-title":"Dig. Liver Dis."},{"issue":"10","key":"10.1016\/j.jneuroim.2026.578942_bb0140","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.1007\/s00210-024-03141-4","article-title":"In vivo and ex vivo gene therapy for neurodegenerative diseases: a promise for disease modification","volume":"397","author":"Ebrahimi","year":"2024","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0145","series-title":"The Neuro-Hepatic-Affective Model (NHAM): a Systems Framework for Liver\u2013Brain Modulation of Emotion in Precision Psychiatry","author":"Elfettahi","year":"2025"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/ene.12664","article-title":"Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis","volume":"23","author":"Elia","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0155","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/oby.23400","article-title":"Early metabolic impairment as a contributor to neurodegenerative disease: mechanisms and potential pharmacological intervention","volume":"30","author":"Fakih","year":"2022","journal-title":"Obesity"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2025.1621070","article-title":"Calcium signaling in postsynaptic mitochondria: mechanisms, dynamics, and role in ATP production","volume":"18","author":"Feofilaktova","year":"2025","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0165","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2009.08.001","article-title":"Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders","volume":"30","author":"Fiorucci","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111658","article-title":"Epigenetic explorations of neurological disorders, the identification methods, and therapeutic avenues","volume":"25","author":"Firdaus","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578942_bb0175","first-page":"9","article-title":"Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets","volume":"9","author":"Fleishman","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0180","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1124\/mol.117.111047","article-title":"Effects of farnesoid x receptor activation on arachidonic acid metabolism, NF-kB signaling, and hepatic inflammation","volume":"94","author":"Gai","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0185","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jare.2025.05.039","article-title":"Targeting the bile acid receptor TGR5 with gentiopicroside to activate nrf2 antioxidant signaling and mitigate parkinsons disease in an MPTP mouse model","volume":"80","author":"Gao","year":"2026","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0190","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1517\/13543776.2012.733000","article-title":"Patented TGR5 modulators: a review (2006 - present)","volume":"22","author":"Gioiello","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21175982","article-title":"Bile acid signaling in neurodegenerative and neurological disorders","volume":"21","author":"Grant","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0200","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/WNR.0000000000001717","article-title":"Identification of the expression of farnesoid x receptor in astrocytes","volume":"32","author":"He","year":"2021","journal-title":"Neuroreport"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0205","series-title":"The Brain, the Nervous System, and Their Diseases: Volumes 1-3","first-page":"668","article-title":"Motor neurons","volume":"2","author":"Hellier","year":"2014"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2015.00070","article-title":"Deletion of mouse FXR gene disturbs multiple neurotransmitter systems and alters neurobehavior","volume":"9","author":"Huang","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0215","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1002\/1873-3468.12373","article-title":"Identification of functional farnesoid x receptors in brain neurons","volume":"590","author":"Huang","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0220","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuroscience.2022.02.028","article-title":"TGR5 agonist INT-777 alleviates inflammatory neurodegeneration in parkinsons disease mouse model by modulating mitochondrial dynamics in microglia","volume":"490","author":"Huang","year":"2022","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0225","first-page":"540","article-title":"Ginsenoside-Rg1 combined with a conditioned medium from induced neuron-like hUCMSCs alleviated the apoptosis in a cell model of ALS through regulating the NF-\u03baB\/Bcl-2 pathway","volume":"21","author":"Huang","year":"2023","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0230","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/19768354.2014.987318","article-title":"Essential roles of bile acid receptors FXR and TGR5 as metabolic regulators","volume":"18","author":"Jacinto","year":"2014","journal-title":"Anim. Cells Syst. (Seoul)."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0235","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molmet.2018.01.005","article-title":"Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR","volume":"9","author":"Jadhav","year":"2018","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0240","series-title":"Neuroprotective Agents 45\u2013173","author":"Jain","year":"2019"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0245","series-title":"Bile Acids Signaling As A Novel Mechanism In The Hypothalamic Control of Energy Balance","first-page":"255","author":"Jankiewicz","year":"2019"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0250","series-title":"Small Molecules in Neurodegeneration","first-page":"111","article-title":"Neurotrophic factors and small molecule mimetics","author":"Jeelani","year":"2025"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0255","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1096\/fj.201700984RR","article-title":"Dysregulated bile acid synthesis and dysbiosis are implicated in western diet\u2013induced systemic inflammation, microglial activation, and reduced neuroplasticity","volume":"32","author":"Jena","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0260","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/med.21653","article-title":"Expert insights: the potential role of the gut microbiome-bile acid-brain axis in the development and progression of alzheimers disease and hepatic encephalopathy","volume":"40","author":"Jia","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578942_bb0265","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10072-024-07878-x","article-title":"The microbiota-gut-brain axis: a potential target in the small-molecule compounds and gene therapeutic strategies for Parkinsons disease","volume":"46","author":"Jiao","year":"2024","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578942_bb0270","doi-asserted-by":"crossref","DOI":"10.1007\/s11011-025-01552-7","article-title":"Unraveling the role of nrf2 in dopaminergic neurons: a review of oxidative stress and mitochondrial dysfunction in Parkinsons disease","volume":"40","author":"Kaur","year":"2025","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0275","doi-asserted-by":"crossref","first-page":"10671","DOI":"10.1073\/pnas.162362299","article-title":"Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of huntingtons disease","volume":"99","author":"Keene","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0280","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-0038-1669940","article-title":"Role of TGR5 (GPBAR1) in liver disease","volume":"38","author":"Keitel","year":"2018","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0285","series-title":"Mammalian Sterols: Novel Biological Roles of Cholesterol Synthesis Intermediates, Oxysterols and Bile Acids","first-page":"81","article-title":"Bile acids and TGR5 (gpbar1) signaling","author":"Keitel","year":"2020"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578942_bb0290","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-022-00307-z","article-title":"Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases","volume":"11","author":"Khalaf","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0295","article-title":"Probiotics as potential treatments for neurodegenerative diseases: a review of the evidence from in vivo to clinical trial","volume":"33","author":"Kim","year":"2024","journal-title":"Biomol. Ther. (Seoul)."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/biom9060232","article-title":"The biosynthesis, signaling, and neurological functions of bile acids","volume":"9","author":"Kiriyama","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0305","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/hep.29569","article-title":"A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis","volume":"67","author":"Kowdley","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051046","article-title":"Cholesterol and the safety factor for neuromuscular transmission","volume":"20","author":"Krivoi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0315","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1007\/s10072-024-07508-6","article-title":"Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches","volume":"45","author":"Kubat","year":"2024","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578942_bb0320","first-page":"9","article-title":"Therapeutic modulation of JAK-STAT, mTOR, and PPAR-\u03b3 signaling in neurological dysfunctions","volume":"101","author":"Kumar","year":"2022","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0325","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40035-017-0102-8","article-title":"Quercetin prevents spinal motor neuron degeneration induced by chronic excitotoxic stimulus by a sirtuin 1-dependent mechanism","volume":"6","author":"Lazo-Gomez","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0330","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/17460441.2024.2387791","article-title":"Promising animal models for amyotrophic lateral sclerosis drug discovery: a comprehensive update","volume":"19","author":"Lescouz\u00e8res","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578942_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/metabo11010029","article-title":"Gut microbiota dysbiosis is associated with elevated bile acids in Parkinsons disease","volume":"11","author":"Li","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113087","article-title":"NR1H4 ameliorates parkinsons disease via inhibiting astrocyte activation and neuroinflammation in a CEBP\u03b2\/NF-\u03baB dependent manner","volume":"142","author":"Li","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0345","article-title":"The brain\u2013gut\u2013bone axis in neurodegenerative diseases: insights, challenges, and future prospects","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10040860","article-title":"Gut microbiota ecosystem governance of host inflammation, mitochondrial respiration and skeletal homeostasis","volume":"10","author":"Lian","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1667180","article-title":"Pathogenesis and intervention strategies for metabolic dysfunction\u2013associated fatty liver disease from the perspective of the gut\u2013microbiota\u2013liver axis","volume":"17","author":"Liao","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0360","article-title":"Crosstalk between bile acids and intestinal epithelium: multidimensional roles of farnesoid x receptor and Takeda G protein receptor 5","volume":"26","author":"Lin","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0365","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/00365521.2021.1903547","article-title":"Progress in research on the roles of TGR5 receptor in liver diseases","volume":"56","author":"Ma","year":"2021","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.875593","article-title":"Reduced peroxisome proliferator-activated receptor-\u03b1 and bile acid nuclear receptor NR1H4\/FXR may affect the hepatic immune microenvironment of biliary atresia","volume":"13","author":"Ma","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0375","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1878-5085-4-5","article-title":"Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?","volume":"4","author":"M\u00e4hler","year":"2013","journal-title":"EPMA J."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0380","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s13311-013-0253-y","article-title":"Resveratrol improves motoneuron function and extends survival in SOD1G93A ALS mice","volume":"11","author":"Mancuso","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0385","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1389200216666151103115454","article-title":"Bile acids in physiology, pathology and pharmacology","volume":"17","author":"Marin","year":"2015","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.723450","article-title":"Frontotemporal pathology in motor neuron disease phenotypes: insights from neuroimaging","volume":"12","author":"McKenna","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0395","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3346\/jkms.2012.27.2.200","article-title":"Oral solubilized ursodeoxycholic acid therapy in amyotrophic lateral sclerosis: a randomized cross-over trial","volume":"27","author":"Min","year":"2012","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0400","first-page":"1","article-title":"FXR crosstalk with other nuclear receptors","volume":"2025","author":"Mohammed","year":"2025","journal-title":"J. Physiol. Biochem."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.578942_bb0405","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-024-00914-3","article-title":"The changing metabolic landscape of bile acids \u2013 keys to metabolism and immune regulation","volume":"21","author":"Mohanty","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578942_bb0410","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12017-020-08625-z","article-title":"Bile acids: a communication channel in the gut-brain axis","volume":"23","author":"Monteiro-Cardoso","year":"2020","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0415","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13023-023-02666-w","article-title":"Chenodeoxycholic acid rescues axonal degeneration in induced pluripotent stem cell-derived neurons from spastic paraplegia type 5 and cerebrotendinous xanthomatosis patients","volume":"18","author":"Mou","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0420","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3716609","article-title":"Activation of TGR5 ameliorates Streptozotocin-induced cognitive impairment by modulating apoptosis, neurogenesis, and neuronal firing","volume":"2022","author":"Mu","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0425","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41583-020-00381-0","article-title":"Gut microbial molecules in behavioural and neurodegenerative conditions","volume":"21","author":"Needham","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063520","article-title":"Disruption of neuromuscular junction following spinal cord injury and motor neuron diseases","volume":"25","author":"Nemeth","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578942_bb0435","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13041-020-0561-1","article-title":"Unveiling synapse pathology in spinal bulbar muscular atrophy by genome-wide transcriptome analysis of purified motor neurons derived from disease specific iPSCs","volume":"13","author":"Onodera","year":"2020","journal-title":"Molecular brain"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11033-025-10368-8","article-title":"Pharmacological approaches to enhance mitochondrial biogenesis: focus on PGC-1\u0391, AMPK, and SIRT1 in cellular health","volume":"52","author":"Palabiyik","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0445","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/WNF.0b013e3181c47569","article-title":"Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic acid in patients with amyotrophic lateral sclerosis","volume":"33","author":"Parry","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0450","first-page":"199","article-title":"Axonal degeneration, impaired axonal transport, and synaptic dysfunction in motor neuron disorder","author":"Parveen","year":"2024","journal-title":"Mech. Neurological Dis."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0455","first-page":"197","article-title":"The discovery of obeticholic acid (ocaliva\u2122): first-in-class FXR agonist","volume":"3","author":"Pellicciari","year":"2018","journal-title":"Curr. Drug Discov."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0460","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202300148","article-title":"An intestinal FXR agonist mitigates dysbiosis, intestinal tight junctions, and inflammation in high-fat diet-fed mice","volume":"68","author":"Petito-da-Silva","year":"2024","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0465","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ijms241512486","article-title":"Exploring Molecular Targets for Mitochondrial Therapies in Neurodegenerative Diseases","volume":"24","author":"Plascencia-Villa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-023-02866-y","article-title":"Lysosomal acidification dysfunction in microglia: An emerging pathogenic mechanism of neuroinflammation and neurodegeneration","volume":"20","author":"Quick","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2025.123581","article-title":"Chitosan nanovectors for siRNA delivery: new horizons for nonviral gene therapy","volume":"360","author":"Rahimi","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0480","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113045","article-title":"Linking nonalcoholic fatty liver disease and brain disease: focusing on bile acid signaling","volume":"23","author":"Ren","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0485","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1124\/mol.110.064501","article-title":"Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid x receptor and TGR5 agonist","volume":"78","author":"Rizzo","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0490","article-title":"Deciphering oxidative stress in cardiovascular disease progression: a blueprint for mechanistic understanding and therapeutic innovation","volume":"14","author":"Rocca","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25179279","article-title":"Emerging roles of bile acids and TGR5 in the central nervous system: molecular functions and therapeutic implications","volume":"25","author":"Romero-Ram\u00edrez","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0500","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1097\/MS9.0000000000002433","article-title":"Bile acid modulation by gut microbiota: a bridge to understanding cognitive health","volume":"86","author":"Sabahat","year":"2024","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0505","doi-asserted-by":"crossref","DOI":"10.1080\/17474124.2020.1797485","article-title":"An insight into primary biliary cholangitis and its recent advances in treatment: semi-synthetic analogs to combat ursodeoxycholic-acid resistance","author":"Sahu","year":"2020","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/biom11081109","article-title":"How inflammation pathways contribute to cell death in neuro-muscular disorders","volume":"11","author":"Salucci","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0515","article-title":"Nigrostriatal dopaminergic vulnerability in Parkinson\u2019s Disease: neuroprotective strategies","author":"Santana-Rom\u00e1n","year":"2025","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578942_bb0520","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01838-w","article-title":"Farnesoid x receptor knockout protects brain against ischemic injury through reducing neuronal apoptosis in mice","volume":"17","author":"Shan","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0525","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157644","article-title":"Neuroaxonal degeneration as a converging mechanism in motor neuron diseases (MNDs): molecular insights into RNA dysregulation and emerging therapeutic targets","volume":"26","author":"Sharbafshaaer","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"127","key":"10.1016\/j.jneuroim.2026.578942_bb0530","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12017-025-08870-0","article-title":"Dysbiosis and neurodegeneration in ALS: unraveling the gut\u2013brain axis","volume":"27","author":"Sharma","year":"2025","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0535","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1210\/me.2013-1353","article-title":"Synthetic FXR agonist GW4064 is a modulator of multiple G protein\u2013coupled receptors","volume":"28","author":"Singh","year":"2014","journal-title":"Mol. Endocrinol."},{"issue":"10","key":"10.1016\/j.jneuroim.2026.578942_bb0540","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00109-022-02240-0","article-title":"Adhesion g protein-coupled receptor gluing action guides tissue development and disease","volume":"100","author":"Sreepada","year":"2022","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262412167","article-title":"Gut\u2013brain axis and bile acid signaling: linking microbial metabolism to brain function and metabolic regulation","volume":"26","author":"Stanimirov","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578942_bb0550","doi-asserted-by":"crossref","DOI":"10.1007\/s11940-025-00835-9","article-title":"Drug combination to slow down the progression of amyotrophic lateral sclerosis","volume":"27","author":"Torres-Rico","year":"2025","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0555","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000371904","article-title":"Potential of nor-Ursodeoxycholic acid in cholestatic and metabolic disorders","volume":"33","author":"Trauner","year":"2015","journal-title":"Dig. Dis."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0560","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/jnc.14001","article-title":"Neuronal and microglial mechanisms for neuropathic pain in the spinal dorsal horn and anterior cingulate cortex","volume":"141","author":"Tsuda","year":"2017","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.578942_bb0565","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11274-025-04395-7","article-title":"The gut microbiota-bile acid axis: a crucial regulator of immune function and metabolic health","volume":"41","author":"Tyagi","year":"2025","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0570","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.nbd.2016.01.004","article-title":"Mitochondria controlled by UCP2 determine hypoxia-induced synaptic remodeling in the cortex and hippocampus","volume":"90","author":"Varela","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0575","first-page":"66","article-title":"Microbial metabolites and the gut-brain axis in neurological disorders: implications for neuropharmacology and therapy","volume":"2","author":"Wang","year":"2025","journal-title":"NPT"},{"issue":"8","key":"10.1016\/j.jneuroim.2026.578942_bb0580","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1007\/s12035-023-03340-9","article-title":"Connecting the gut microbiota and neurodegenerative diseases: the role of bile acids","volume":"60","author":"Wang","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0585","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.70146","article-title":"CGAS\u2013STING signaling in central nervous system diseases: Neuroinflammatory mechanisms and immune regulation","volume":"43","author":"Wang","year":"2025","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu13030940","article-title":"Obeticholic acid inhibits anxiety via alleviating gut microbiota-mediated microglia accumulation in the brain of high-fat high-sugar diet mice","volume":"13","author":"Wu","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0595","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1111\/cns.14154","article-title":"Activation of the bile acid receptors TGR5 and FXR in the spinal dorsal horn alleviates neuropathic pain","volume":"29","author":"Wu","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0600","first-page":"1","article-title":"Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases\u2014an update","author":"Wu","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0605","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.4103\/NRR.NRR-D-24-01371","article-title":"Role of peroxisome proliferator-activated receptor alpha in neurodegenerative diseases and other neurological disorders: clinical application prospects","volume":"21","author":"Wu","year":"2026","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578942_bb0610","first-page":"1","article-title":"Roles of bile acids signaling in neuromodulation under physiological and pathological conditions","volume":"13","author":"Xing","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0615","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2264850","article-title":"Safety, tolerability, pharmacokinetics and pharmacodynamics of a novel farnesoid x receptor (FXR) agonist-TQA3526 in healthy chinese volunteers: a double-blind, randomized, placebo-controlled, dose-escalation, food effect phase i study","volume":"55","author":"Xu","year":"2023","journal-title":"Ann. Med."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0620","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.567650","article-title":"Pathophysiologic role of neurotransmitters in digestive diseases","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0625","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1002\/med.21705","article-title":"Modern approaches in gene therapy of motor neuron diseases","volume":"41","author":"Zakharova","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119252","article-title":"The bile acid TUDCA and neurodegenerative disorders: An overview","volume":"272","author":"Zangerolamo","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0635","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26146547","article-title":"The critical role of the bile acid receptor TGR5 in energy homeostasis: insights into physiology and therapeutic potential","volume":"26","author":"Zangerolamo","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0640","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tox.2017.01.007","article-title":"Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation","volume":"378","author":"Zhang","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.jneuroim.2026.578942_bb0645","article-title":"cGAS-STING axis: A central regulator of neural homeostasis and neuroinflammatory pathogenesis","author":"Zhang","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0650","article-title":"cGAS\u2013STING pathway modulation: A new hope for neural regeneration","author":"Zhang","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0655","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4103\/NRR.NRR-D-24-01412","article-title":"Regulation of synaptic function and lipid metabolism","volume":"21","author":"Zhang","year":"2026","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0660","article-title":"Research progress on the mechanism of bile acids and their receptors in depression","volume":"26","author":"Zhao","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0665","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cmet.2021.12.011","article-title":"Emerging targetome and signalome landscape of gut microbial metabolites","volume":"34","author":"Zheng","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0670","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.981963","article-title":"Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling","volume":"9","author":"Zhou","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jneuroim.2026.578942_bb0675","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1634548","article-title":"Mechanisms of the effect of gut microbes on depression through the microbiota-gut-brain axis","volume":"12","author":"Zhou","year":"2025","journal-title":"Front. Nutr."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826000901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826000901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:54:37Z","timestamp":1784552077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826000901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":135,"alternative-id":["S0165572826000901"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.578942","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TGR5 and FXR receptors in motor degeneration: Molecular mechanism, crosstalk pathways and therapeutic prospects","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.578942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"578942"}}